CytoDyn Inc.
CYDY
$0.25
-$0.01-2.40%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -308.07% | 6.98% | -25.18% | 0.21% | -124.80% |
| Total Depreciation and Amortization | 25.00% | 0.00% | -20.00% | 25.00% | -20.00% |
| Total Amortization of Deferred Charges | -- | -- | -46.36% | -2.65% | -9.60% |
| Total Other Non-Cash Items | 169.83% | -70.12% | 4,507.69% | -97.16% | -78.92% |
| Change in Net Operating Assets | 511.25% | 887.80% | -13.19% | -153.62% | 103.78% |
| Cash from Operations | -77.55% | 56.74% | -14.27% | -38.20% | -165.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -100.00% | -98.20% | 5,452.38% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 100.00% | -110.38% | 5,452.38% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.19% | 42.83% | 8.88% | -37.62% | -123.74% |